5-HT 1A receptor sensitivity in 5-HT 1B receptor KO mice is unaffected by chronic fluvoxamine treatment

European Journal of Pharmacology

Volumn 667, Issue 1-3, 2011, Pages 250-257

  Vinkers, Christiaan H ^a,b   Groenink, Lucianne ^a   Pattij, Tommy ^c   Olivier, Berend ^a,d   Bouwknecht, J Adriaan ^e  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

5 HT; 5 HT 1B receptor; 5 HTT; 5HT 1A receptor; Antidepressant; Knockout; SERT; SIH; SSRI; Stress induced hyperthermia

Indexed keywords

SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BODY TEMPERATURE MEASUREMENT; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; ENVIRONMENTAL STRESS; HEART RATE VARIABILITY; KNOCKOUT MOUSE; LOCOMOTION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; RECEPTOR SENSITIVITY; WILD TYPE;

ANIMALS; BODY TEMPERATURE; FLUVOXAMINE; GENE KNOCKOUT TECHNIQUES; HEART RATE; MALE; MICE; MOTOR ACTIVITY; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT1B; SEROTONIN UPTAKE INHIBITORS; STRESS, PHYSIOLOGICAL; TIME FACTORS;

EID: 80052034593     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.06.018     Document Type: Article

References (39)

1. A.R. Ase, T.A. Reader, R. Hen, M. Riad, and L. Descarries Regional changes in density of serotonin transporter in the brain of 5-HT1A and 5-HT1B knockout mice, and of serotonin innervation in the 5-HT1B knockout J. Neurochem. 78 2001 619 630 (Pubitemid 32729990)
2. J. Beique, C. de Montigny, P. Blier, and G. Debonnel Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. In vivo electrophysiological studies in the rat Neuropharmacology 39 2000 1800 1812 (Pubitemid 30398484)
3. N. Bel, and F. Artigas Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei Synapse 15 1993 243 245 (Pubitemid 23339517)
4. P. Blier Pharmacology of rapid-onset antidepressant treatment strategies J. Clin. Psychiatry 62 Suppl. 15 2001 12 17 (Pubitemid 32601343)
5. P. Blier The pharmacology of putative early-onset antidepressant strategies Eur. Neuropsychopharmacol. 13 2003 57 66 (Pubitemid 36313278)
6. F.J. Bosker, A.A. Klompmakers, and H.G. Westenberg Effects of single and repeated oral administration of fluvoxamine on extracellular serotonin in the median raphe nucleus and dorsal hippocampus of the rat Neuropharmacology 34 1995 501 508
7. F.J. Bosker, K.E. van Esseveldt, A.A. Klompmakers, and H.G. Westenberg Chronic treatment with fluvoxamine by osmotic minipumps fails to induce persistent functional changes in central 5-HT1A and 5-HT1B receptors, as measured by in vivo microdialysis in dorsal hippocampus of conscious rats Psychopharmacology (Berl.) 117 1995 358 363
8. J.A. Bouwknecht, T.H. Hijzen, J. van der Gugten, R.A. Maes, R. Hen, and B. Olivier Absence of 5-HT(1B) receptors is associated with impaired impulse control in male 5-HT(1B) knockout mice Biol. Psychiatry 49 2001 557 568 (Pubitemid 32289349)
9. J.A. Bouwknecht, J. van der Gugten, T.H. Hijzen, R.A. Maes, R. Hen, and B. Olivier Male and female 5-HT(1B) receptor knockout mice have higher body weights than wildtypes Physiol. Behav. 74 2001 507 516 (Pubitemid 34076596)
10. J.A. Bouwknecht, T.H. Hijzen, J. van der Gugten, R.A. Maes, R. Hen, and B. Olivier 5-HT(1B) receptor knockout mice show no adaptive changes in 5-HT(1A) receptor function as measured telemetrically on body temperature and heart rate responses Brain Res. Bull. 57 2002 93 102 (Pubitemid 34097774)
11. J.A. Bouwknecht, B. Olivier, and R.E. Paylor The stress-induced hyperthermia paradigm as a physiological animal model for anxiety: a review of pharmacological and genetic studies in the mouse Neurosci. Biobehav. Rev. 31 2007 41 59 (Pubitemid 44880072)
12. L.A. Dawson, H.Q. Nguyen, D.L. Smith, and L.E. Schechter Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex J. Psychopharmacol. 16 2002 145 152 (Pubitemid 34614884)
13. L. De Groote, B. Olivier, and H.G. Westenberg The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT(1B) receptor knockout mice Eur. J. Pharmacol. 439 2002 93 100 (Pubitemid 34286611)
14. L. de Groote, B. Olivier, and H.G. Westenberg Extracellular serotonin in the prefrontal cortex is limited through terminal 5-HT(1B) autoreceptors: a microdialysis study in knockout mice Psychopharmacology (Berl.) 162 2002 419 424 (Pubitemid 35001905)
15. J.A. Den Boer, F.J. Bosker, and B.R. Slaap Serotonergic drugs in the treatment of depressive and anxiety disorders Hum. Psychopharmacol. 15 2000 315 336 (Pubitemid 30481102)
16. A. Evrard, A.M. Laporte, M. Chastanet, R. Hen, M. Hamon, and J. Adrien 5-HT1A and 5-HT1B receptors control the firing of serotoninergic neurons in the dorsal raphe nucleus of the mouse: studies in 5-HT1B knock-out mice Eur. J. Neurosci. 11 1999 3823 3831 (Pubitemid 29537562)
17. A.M. Gardier, B. Gruwez, A.C. Trillat, C. Jacquot, R. Hen, and M. Bourin Interaction between 5-HT(1A) and 5-HT(1B) receptors: effects of 8-OH-DPAT-induced hypothermia in 5-HT(1B) receptor knockout mice Eur. J. Pharmacol. 421 2001 171 175 (Pubitemid 32539418)
18. A.M. Gardier, D.J. David, G. Jego, C. Przybylski, C. Jacquot, S. Durier, B. Gruwez, E. Douvier, P. Beauverie, N. Poisson, R. Hen, and M. Bourin Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice J. Neurochem. 86 2003 13 24 (Pubitemid 36753841)
19. M. Geldof, J.I. Freijer, L. van Beijsterveldt, X. Langlois, and M. Danhof Pharmacokinetic-pharmacodynamic modelling of fluvoxamine 5-HT transporter occupancy in rat frontal cortex Br. J. Pharmacol. 154 2008 1369 1378 (Pubitemid 351992054)
20. J. Hannon, and D. Hoyer Molecular biology of 5-HT receptors Behav. Brain Res. 195 2008 198 213
21. S. Hjorth, H.J. Bengtsson, A. Kullberg, D. Carlzon, H. Peilot, and S.B. Auerbach Serotonin autoreceptor function and antidepressant drug action J. Psychopharmacol. 14 2000 177 185 (Pubitemid 30389492)
22. J. Hyttel Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs) Int. Clin. Psychopharmacol. 9 Suppl. 1 1994 19 26 (Pubitemid 24107713)
23. R. Invernizzi, M. Bramante, and R. Samanin Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex Pharmacol. Biochem. Behav. 54 1996 143 147
24. M.E. Jongsma, F.J. Bosker, T.I. Cremers, B.H. Westerink, and J.A. den Boer The effect of chronic selective serotonin reuptake inhibitor treatment on serotonin 1B receptor sensitivity and HPA axis activity Prog. Neuropsychopharmacol. Biol. Psychiatry 29 2005 738 744 (Pubitemid 40897785)
25. D.A. Knobelman, R. Hen, J.A. Blendy, and I. Lucki Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse J. Pharmacol. Exp. Ther. 298 2001 1092 1100 (Pubitemid 32761925)
26. J.M. Koolhaas, S.F. de Boer, C.M. Coppens, and B. Buwalda Neuroendocrinology of coping styles: towards understanding the biology of individual variation Front. Neuroendocrinol. 31 2010 307 321
27. I. Malagie, A.C. Trillat, M. Bourin, C. Jacquot, R. Hen, and A.M. Gardier 5-HT1B Autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex J. Neurochem. 76 2001 865 871 (Pubitemid 32126086)
28. I. Malagie, D.J. David, P. Jolliet, R. Hen, M. Bourin, and A.M. Gardier Improved efficacy of fluoxetine in increasing hippocampal 5-hydroxytryptamine outflow in 5-HT(1B) receptor knock-out mice Eur. J. Pharmacol. 443 2002 99 104 (Pubitemid 34603603)
29. G. Malleret, R. Hen, J.L. Guillou, L. Segu, and M.C. Buhot 5-HT1B receptor knock-out mice exhibit increased exploratory activity and enhanced spatial memory performance in the Morris water maze J. Neurosci. 19 1999 6157 6168 (Pubitemid 29327947)
30. J.W. Murrough, S. Henry, J. Hu, J.D. Gallezot, B. Planeta-Wilson, J.F. Neumaier, and A. Neumeister Reduced ventral striatal/ventral pallidal serotonin(1B) receptor binding potential in major depressive disorder Psychopharmacology (Berl.) 213 2-3 2011 547 553
31. M. Naughton, J.B. Mulrooney, and B.E. Leonard A review of the role of serotonin receptors in psychiatric disorders Hum. Psychopharmacol. 15 2000 397 415
32. B.M. Ruf, and Z. Bhagwagar The 5-HT1B receptor: a novel target for the pathophysiology of depression Curr. Drug Targets 10 2009 1118 1138
33. F. Saudou, D.A. Amara, A. Dierich, M. LeMeur, S. Ramboz, L. Segu, M.C. Buhot, and R. Hen Enhanced aggressive behavior in mice lacking 5-HT1B receptor Science 265 1994 1875 1878
34. N.A. Shanahan, K.A. Holick Pierz, V.L. Masten, C. Waeber, M. Ansorge, J.A. Gingrich, M.A. Geyer, R. Hen, and S.C. Dulawa Chronic reductions in serotonin transporter function prevent 5-HT1B-induced behavioral effects in mice Biol. Psychiatry 65 2009 401 408
35. I. Skelin, F. Yamane, and M. Diksic Flesinoxan challenge suggests that chronic treatment with paroxetine in rats does not desensitize receptors controlling 5-HT synthesis Neurochem. Int. 53 2008 236 243
36. M.J. van Bogaert, L. Groenink, R.S. Oosting, K.G. Westphal, J. van der Gugten, and B. Olivier Mouse strain differences in autonomic responses to stress Genes Brain Behav. 5 2006 139 149 (Pubitemid 43348555)
37. J.A. Van der Heyden, T.J. Zethof, and B. Olivier Stress-induced hyperthermia in singly housed mice Physiol. Behav. 62 1997 463 470 (Pubitemid 27376279)
38. S.M. Villafuerte, K. Vallabhaneni, E. Sliwerska, F.J. McMahon, E.A. Young, and M. Burmeister SSRI response in depression may be influenced by SNPs in HTR1B and HTR1A Psychiatr. Genet. 19 2009 281 291
39. C.H. Vinkers, M.J. van Bogaert, M. Klanker, S.M. Korte, R. Oosting, T. Hanania, S.C. Hopkins, B. Olivier, and L. Groenink Translational aspects of pharmacological research into anxiety disorders: the stress-induced hyperthermia (SIH) paradigm Eur. J. Pharmacol. 585 2008 407 425